Drug · DIN 02264609
IPRAMOL
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 24, 2018.
- Drug Identification Number (DIN)
- 02264609
- Company (DIN owner)
- Ivax Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Inhalation
- Therapeutic class (ATC)
- Salbutamol and ipratropium bromide R03AL02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SALBUTAMOL (SALBUTAMOL SULFATE) | 2.5 MG | 2.5 ML |
| IPRATROPIUM BROMIDE | 0.5 MG | 2.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 14, 2005: NOC 6287Abbreviated New Drug Submission (ANDS)